Page last updated: 2024-09-03

dn 1417 and levodopa

dn 1417 has been researched along with levodopa in 1 studies

Compound Research Comparison

Studies
(dn 1417)
Trials
(dn 1417)
Recent Studies (post-2010)
(dn 1417)
Studies
(levodopa)
Trials
(levodopa)
Recent Studies (post-2010) (levodopa)
942017,7741,9004,946

Protein Interaction Comparison

ProteinTaxonomydn 1417 (IC50)levodopa (IC50)
integrase, partialHuman immunodeficiency virus 10.5939
lens epithelium-derived growth factor p75Homo sapiens (human)0.5939
Epidermal growth factor receptorHomo sapiens (human)2.88
Tyrosine-protein kinase LckHomo sapiens (human)3.729
Tyrosine-protein kinase FynHomo sapiens (human)2.146
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.258

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagai, Y; Nagawa, Y; Narumi, S; Saji, Y1

Other Studies

1 other study(ies) available for dn 1417 and levodopa

ArticleYear
[A TRH analog (DN-1417). Anti-reserpine action in electroconvulsive threshold and involvement of serotonergic (5-HT) mechanism in mice].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1985, Volume: 85, Issue:4

    Topics: 5-Hydroxytryptophan; Animals; Anticonvulsants; Biogenic Amines; Brain Chemistry; Drug Interactions; Electroshock; Levodopa; Male; Mice; Mice, Inbred ICR; Reserpine; Seizures; Serotonin; Thyrotropin-Releasing Hormone

1985